PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...
The Tropis ® intradermal (ID) Needle-free Injection System overcomes the challenges of traditional Mantoux injection and can easily be integrated into commercial products and development projects.
PharmaJet (R) , a company focused on improving the performance and outcomes of injectables through needle-free injection technology, announced that its partner, Brazilian Tuberculosis Research Network ...
PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its needle-free injection technology, will present at the American Society of Tropical Medicine and ...
PharmaJet has struck an agreement covering the use of its Tropis needle-free injection system in Nigeria, positioning vaccinators to deploy the technology in a project intended to tackle a poliovirus ...
Flu vaccine makers began shipping on Monday a new form of the annual flu shot, with a significantly shorter needle. The new vaccine should make it easier for people with a fear of needles to get ...
UK researchers are trialling an innovative needle-free vaccine candidate called DIOS-CoVax, that could offer protection against emerging SARS-CoV-2 variants and other coronaviruses likely to cause ...
This is the third article in a series on next-generation mRNA vaccines. The first two installments can be read here and here, respectively. Messenger RNA (mRNA) technology has been central to the ...
PharmaJet's Needle-free Tropis is being evaluated in a clinical study by REDE-TB as a potential improvement on the TB skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results